Fenebrutinib (GDC-0853)
CAS: 1434048-34-6
Ref. 3D-JHC04834
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
Fenebrutinib is a long-acting monoclonal antibody that inhibits the activity of stem cell factor. It binds to the stem cell factor, preventing it from binding to its receptor and causing platelets to aggregate. Fenebrutinib has been shown to be safe and effective in preclinical studies for heparin-induced thrombocytopenia and related conditions, including autoimmune diseases such as rheumatoid arthritis. Fenebrutinib is being developed as a treatment for cancer, inflammatory bowel disease, and other autoimmune disorders. This drug is selective for c-KIT (a type of enzyme called kinase) but does not affect other kinases such as JAK1 or JAK2.
Propiedades químicas
Consulta técnica sobre: 3D-JHC04834 Fenebrutinib (GDC-0853)
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
